Ion’s Wrists Slapped in Probe of Broadway Deal

The competition watchdog extends its initial investigation after Ion failed to comply with a call for info.

Ion-Group-headquarters-One-New-Change
Ion Group's headquarters in London's One New Change complex
Flickr | Peter Alfred Hess

Trading systems giant Ion Group has received a telling-off from the UK’s competition watchdog as part of an ongoing probe into the firm’s acquisition of rival vendor Broadway Technology.

On April 23, the Competition and Markets Authority said Ion had failed to comply with a notice calling for “information and documents” to be provided by midnight the previous day. The time available for the CMA’s initial probe—originally set to conclude on June 17—will be extended as a result.

The slap on the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

Preparing for the gathering storm

The Markets in Crypto-Assets (Mica) regulation came into force across the European Union on June 29 to enhance the transparency and integrity of the industry’s burgeoning crypto markets. Travis Schwab, CEO of Eventus, discusses his firm’s Mica strategy…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here